fda warning letters compounded semaglutide tirzepatide 2024 2025 A company called Nomida has received an letter for offering for sale injectable weight-loss treatments. None of their offerings are FDA-approved. Nomida is allegedly selling unapproved and "kits" FDA warns Ozempic and Mounjaro

The US Food and Drug Administration approveddrugmaker Novo Nordisks application to add cardiovascular benefits to the medicines label, making it the first weight-loss drug to also be cleared to reduce the risk of heart attack, stroke or heart-related death in people at higher risk of these conditions.

Fierce Healthcare article, 9 May 2023: [12] Thomas CE, Mauer EA, Shukla AP, Rathi S, Aronne LJ

Combination of Vitamins, Amino Acids - Manage and Treat Type 2 Diabetes.

So, it's no surprise that several wellness- and supplement-focused brands have launched products intended to meet the moment, though each of the products discussed in this piece positions itself slightly differently and uses different ingredients

nejm.org+2Wikipedia+2